Our results illustrated that the expression levels of MMP-2 and MMP-9 are associated with the pathological grades of the tumor[5]–[6], providing strong evidence that MMPs expression can be used as a criterion to determine the malignant phenotypes of gliomas. This evidence concerns the gene MMP9 and central nervous system cancer.